GlassScriptPhysician profile
Jasmine Pedroso
NPI 1962632216
$3,303.06
in general payments reported to CMS, 2019-2025
25 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,848 · 2020: $425 · 2021: $76.12 · 2022: $336 · 2023: $300 · 2024: $185 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $551.12 | 2019-2022 | |
| Caldera Medical, INC | $319.49 | 2019 | |
| Coloplast Corp | $246.22 | 2019 | |
| Hologic Sales and Service, LLC | $215.27 | 2020-2022 | |
| Boston Scientific Corporation | $180.12 | 2019 | |
| Lsi Solutions INC | $153.31 | 2019-2021 | |
| Acessa Health INC. | $150.86 | 2019 | |
| Ethicon US, LLC | $150.65 | 2020 | |
| Conmed Corporation | $145.83 | 2019 | |
| Baxter Healthcare | $133.33 | 2023 | Tisseel |
| Minerva Surgical, INC | $118.46 | 2019-2024 | |
| Astellas Pharma Global Development | $116.63 | 2025 | Veozah |
| Gynesonics, INC. | $116.00 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pacira Pharmaceuticals Incorporated | $109.56 | 2023 | Exparel, Iovera |
| Intuitive Surgical, INC. | $100.41 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $95.81 | 2019 | |
| Apyx Medical Corporation | $94.37 | 2019 | |
| Ferring Pharmaceuticals INC. | $79.41 | 2021-2023 | |
| Organon LLC | $54.49 | 2023-2025 | Ganirelix Acetate, Follistim Aq |
| Coopersurgical, INC. | $44.68 | 2019-2022 | |
| Emd Serono, INC. | $38.05 | 2021-2022 | |
| Meditrina | $30.51 | 2024 | |
| Applied Medical Resources Corporation | $30.36 | 2019 | |
| Novo Nordisk INC | $14.78 | 2020 | |
| Covidien LP | $13.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Pedroso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.